Biotech news
Americas
A Delaware court has dismissed a patent infringement claim brought by Amgen against a biosimilar maker. 28 March 2018
Americas
Novartis and Harvard University have teamed up to develop Harvard’s proprietary biomaterial systems to deliver cancer immunotherapies. 23 March 2018
Americas
Novartis has accused competitor Regeneron of patent infringement through the latter’s sale of Eylea and Zaltrap. 22 March 2018
Biotech
Danish pharmaceutical company Lundbeck has boosted its pipeline of treatments for patients with Parkinson’s disease with the planned acquisition of Prexton Therapeutics. 19 March 2018
Americas
A Californian court has rejected a motion to dismiss a lawsuit involving a treatment for haemophilia A, a genetic blood coagulation disorder. 16 March 2018
Americas
AstraZeneca’s research development arm MedImmune has revealed plans to spin out six molecules into an independent biotech company. 6 March 2018
Americas
Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox. 6 March 2018
Americas
DowDuPont, a specialist in agriculture, materials science and speciality products, has revealed the names of three independent companies that it intends on creating. 1 March 2018
Biotech
The 12th annual BIO-Europe Spring conference, to be held in Amsterdam, the Netherlands on March 12 to 14, 2018, will allow key players in the biotech industry to come together, as Catherine Moreno Finan reports. 1 March 2018
Biotech
The EU General Court has crushed a company’s attempt to protect the Gala Schnico apple variety, today affirming a decision of the Community Plant Variety Office. 23 February 2018